BlackRock Fund Advisors - CANCER GENETICS INC ownership

CANCER GENETICS INC's ticker is CGIXXXXX and the CUSIP is 13739U104. A total of 41 filers reported holding CANCER GENETICS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
BlackRock Fund Advisors ownership history of CANCER GENETICS INC
ValueSharesWeighting
Q4 2016$51,000
-20.3%
37,660
+2.4%
0.00%
Q3 2016$64,000
-12.3%
36,774
-0.2%
0.00%
Q2 2016$73,000
+12.3%
36,862
+60.6%
0.00%
Q1 2016$65,000
-19.8%
22,957
-6.4%
0.00%
Q4 2015$81,000
-55.0%
24,525
+6.4%
0.00%
Q3 2015$180,000
-13.9%
23,041
+29.4%
0.00%
Q2 2015$209,000
+71.3%
17,805
+13.6%
0.00%
Q1 2015$122,000
+90.6%
15,673
+63.6%
0.00%
Q4 2014$64,000
+68.4%
9,579
+127.9%
0.00%
Q3 2014$38,0004,2030.00%
Other shareholders
CANCER GENETICS INC shareholders Q4 2015
NameSharesValueWeighting ↓
DOMINI IMPACT INVESTMENTS LLC 22,203$148,0002.90%
Millrace Asset Group, Inc. 187,184$1,250,0001.30%
Sterneck Capital Management, LLC 60,650$405,0000.24%
GRUBER & MCBAINE CAPITAL MANAGEMENT LLC 83,900$560,0000.15%
Quality Growth Management, Inc. 23,500$157,0000.12%
ARDSLEY ADVISORY PARTNERS LP 50,000$334,0000.05%
DIKER MANAGEMENT LLC 35,015$234,0000.05%
SSI INVESTMENT MANAGEMENT LLC 65,043$434,0000.04%
BANK OF MONTREAL /CAN/ 616,430$4,118,0000.01%
Commonwealth Equity Services, Inc 27,100$181,0000.00%
View complete list of CANCER GENETICS INC shareholders